Bausch Stroebel

Bausch Stroebel

End-to-end pharmaceutical production systems provider

Overview

Bausch Ströbel partners with pharmaceutical manufacturers to provide end-to-end production solutions. Its offerings include filling and closing machines, containment systems, and secondary packaging, which are combined into integrated production lines that cover the full product lifecycle. The machines and systems work together to safely and efficiently fill, seal, and protect medicines and vaccines, while also handling final packaging. The company differentiates itself through its long history as a family-owned business, a global service network, and a close collaboration with major pharmaceutical companies to deliver fully integrated, lifecycle-oriented solutions. Its goal is to help ensure that essential medicines and vaccines are safely, reliably, and affordably available worldwide by delivering dependable equipment, ongoing service, and comprehensive support.

About Bausch Stroebel

Simplify's Rating
Why Bausch Stroebel is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Ilshofen, Germany

Founded

1967

Get referred to Bausch Stroebel

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The May 2026 rapid.tech3D award validates Bausch+Ströbel's additive-manufacturing capability.
  • Shanghai's six-person team should shorten project cycles and accelerate Chinese customer wins in 2026.
  • The 2026 training center openings support recruiting scarce mechatronics and automation talent.

What critics are saying

  • Bausch+Ströbel's March 2026 board reset signals internal pressure on strategic execution.
  • China expansion raises dependency on one market, with localized competitors eroding margins by 2027.
  • Automation rivals can copy features like stopper tracks, compressing differentiation after 2026 awards.

What makes Bausch Stroebel unique

  • Bausch+Ströbel's March 2026 supervisory reshuffle targets faster strategy and personnel decisions.
  • Its Shanghai representative office opened in 2026, deepening China localization after forty years.
  • The VarioSys expertise and training center reinforce pharmaceutical-engineering specialization in Ilshofen.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Company Match

Paid Holidays

Paid Vacation

Company News

Rieckermann
Sep 9th, 2025
RIECKERMANN AT ISPE SINGAPORE 2025

Rieckermann, together with their group member Traque and esteemed industry partners Bausch+Stroebel and Harro Höfliger, proudly participated in the ISPE Conference & Exhibition 2025.

Rieckermann
Oct 2nd, 2024
RIECKERMANN MAKES SECOND APPEARANCE AT THE ISPE SINGAPORE 2024

For the second time, Rieckermann, in collaboration with industry partner Bausch+Ströbel, participated in the ISPE Singapore Affiliate Conference & Exhibition 2024.

Recently Posted Jobs

Sign up to get curated job recommendations

Bausch Stroebel is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →